Category: Clinical Breakthroughs
-
Investigating Birth Outcomes and HIV Drug Regimens
Drugs commonly used to prevent HIV transmission from mother to child during pregnancy were not associated with a higher risk of adverse birth outcomes, according to a new study.
-
A New Weapon Against Cancer Metastasis
Northwestern Medicine scientists have discovered a new compound that halts the spread of multiple types of cancer cells.
-
Chicago Helps Launch All of Us Research Program to Advance Precision Medicine
On May 6, the Illinois Precision Medicine Consortium hosted a launch event at Chicago’s Millennium Park, one of many simultaneous events held around the country to mark the program’s launch.
-
Accelerating Pharmaceutical Discovery
NewCures at Northwestern University is a novel accelerator working to identify promising potential therapies in development, fund research into their viability, and promote their development as new drugs.
-
Feinberg’s Home for Public Health
Within the Institute for Public Health and Medicine (IPHAM), investigators collaborate at the intersection of public health and medicine — connecting clinics to communities and accelerating innovations that impact the health of both patients and populations.
-
Evaluating Drug Regimens for High-Risk Prostate Cancer
The addition of a chemotherapy drug to adjuvant hormone therapy did not improve survival for patients with high-risk prostate cancer, according to a new study.
-
A Wearable Device Intervention to Increase Exercise in Peripheral Artery Disease
A home-based exercise program, consisting of wearables and telephone coaching, did not improve walking endurance for patients with peripheral artery disease, according to a study published in JAMA.
-
Gene Therapy for Thalassemia Shows Promise
In new clinical trials, a gene therapy for a serious blood disorder called beta-thalassemia significantly improved outcomes among patients, without serious side effects.
-
Comparing Strategies to Guide Blood Pressure Treatment
A new study shows a patient’s overall heart disease risk assessment can better determine blood pressure treatment, as opposed to examining blood pressure levels alone.
-
Tracking Quality of Life During Prostate Cancer Treatment
Patients with advanced prostate cancer who received more intensive treatment experienced worse quality of life at three months, but better overall in the long-term, according to a new Northwestern Medicine study.
